Results of conservative surgery and radiation for mammographically detected ductal carcinoma in situ (DCIS)

被引:70
作者
Fowble, B
Hanlon, AL
Fein, DA
Hoffman, JP
Sigurdson, ER
Patchefsky, A
Kessler, H
机构
[1] FOX CHASE CANC CTR, DEPT SURG, PHILADELPHIA, PA 19111 USA
[2] FOX CHASE CANC CTR, DEPT PATHOL, PHILADELPHIA, PA 19111 USA
[3] FOX CHASE CANC CTR, DEPT RADIOL, PHILADELPHIA, PA 19111 USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1997年 / 38卷 / 05期
关键词
ductal carcinoma in situ; breast conservative therapy; mammographically detected DCIS;
D O I
10.1016/S0360-3016(97)00153-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The role of conservative surgery and radiation for mammographically detected ductal carcinoma in situ (DCIS) is controversial. In particular, there is little data for outcome with radiation in a group of patients comparable to those treated with local excision and surveillance (mammographic calcifications less than or equal to 2.5 cm, negative resection margins, negative postbiopsy mammogram). This study reports outcome of conservative surgery and radiation for mammographically detected DCIS with an emphasis on results in patients considered candidates for excision alone. Methods and Materials: From 1983 to 1992, 110 women with mammographically detected DCIS (77% calcifications +/- mass) and no prior history of breast cancer underwent needle localization and biopsy with (55%) or without a reexcision and radiation. Final margins of resection mere negative in 62%, positive 7%, close 11%, and unknown 20%. The median patient age was 56 years. The most common histologic subtype was comedo (54%, followed by cribriform (22%). The median pathologic tumor size was 8 mm (range 2 mm to 5 cm). Forty-seven percent of patients with calcifications only had a negative postbiopsy mammogram prior to radiation. Radiation consisted of treatment to the entire breast (median 50.00 Gy) and a boost to the primary site (97%) for a median total dose of 60.40 Gy. Results: With a median follow-up of 5.3 years, three patients developed a recurrence in the treated breast, The median interval to recurrence was 8.8 gears and all were invasive cancers. Two (67%) occurred outside the initial quadrant. The 5- and 10-year actuarial rates of recurrence were 1 and 15%. Cause-specific survival was 100% at 5 and 10 years. Contralateral breast cancer developed in two patients. There were too few failures for statistical significance to be achieved with any of the following factors: patient age, family history, race, mammographic findings, location primary, pathologic size, histologic subtype, reexcision, or final margin status. However, young age, positive or close margins, and the presence of a mass without calcifications had a trend for an increased risk of recurrence. There were no recurrences in the subset of 16 patients who would be candidates for surveillance by Lagios' criteria. Conclusion: For selected patients, conservative surgery and radiation for mammographically detected DCIS results in a low risk of recurrence in the treated breast and 100% 5- and 10-year cause-specific survival. Improved mammographic and pathologic evaluation results in better patient selection and reduces the risk of the subsequent appearance of DCIS in the biopsy site. The identification of risk factors for an ipsilateral invasive breast recurrence is evolving. (C) 1997 Elsevier Science Inc.
引用
收藏
页码:949 / 957
页数:9
相关论文
共 36 条
  • [1] FOLLOW-UP OF 2 TREATMENT MODALITIES FOR DUCTAL CANCER INSITU OF THE BREAST
    ARNESSON, LG
    SMEDS, S
    FAGERBERG, G
    GRONTOFT, O
    [J]. BRITISH JOURNAL OF SURGERY, 1989, 76 (07) : 672 - 675
  • [2] Incidence of and treatment for ductal carcinoma in situ of the breast
    Ernster, VL
    Barclay, J
    Kerlikowske, K
    Grady, D
    Henderson, IC
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (12): : 913 - 918
  • [3] LUMPECTOMY COMPARED WITH LUMPECTOMY AND RADIATION-THERAPY FOR THE TREATMENT OF INTRADUCTAL BREAST-CANCER
    FISHER, B
    COSTANTINO, J
    REDMOND, C
    FISHER, E
    MARGOLESE, R
    DIMITROV, N
    WOLMARK, N
    WICKERHAM, DL
    DEUTSCH, M
    ORE, L
    MAMOUNAS, E
    POLLER, W
    KAVANAH, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (22) : 1581 - 1586
  • [4] FISHER ER, 1995, CANCER-AM CANCER SOC, V75, P1310, DOI 10.1002/1097-0142(19950315)75:6<1310::AID-CNCR2820750613>3.0.CO
  • [5] 2-G
  • [6] Fourquet, 1992, Semin Radiat Oncol, V2, P116, DOI 10.1016/1053-4296(92)90015-D
  • [7] TREATMENT OF INTRADUCTAL CARCINOMA WITH LIMITED SURGERY - LONG-TERM FOLLOW-UP
    GALLAGHER, WJ
    KOERNER, FC
    WOOD, WC
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (03) : 376 - 380
  • [8] Hiramatsu H, 1995, Cancer J Sci Am, V1, P55
  • [9] NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS
    KAPLAN, EL
    MEIER, P
    [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) : 457 - 481
  • [10] BREAST-CONSERVATION THERAPY FOR INTRADUCTAL CARCINOMA OF THE BREAST
    KUSKE, RR
    BEAN, JM
    GARCIA, DM
    PEREZ, CA
    ANDRIOLE, D
    PHILPOTT, G
    FINEBERG, B
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 26 (03): : 391 - 396